Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review

[1]  Nancy Verzier,et al.  The safety of warfarin therapy in the nursing home setting. , 2007, The American journal of medicine.

[2]  Mark A. Crowther,et al.  Paper-based dosing algorithms for maintenance of warfarin anticoagulation , 2006, Journal of Thrombosis and Thrombolysis.

[3]  Dean F Sittig,et al.  Reducing warfarin medication interactions: an interrupted time series evaluation. , 2006, Archives of internal medicine.

[4]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[5]  Nikki M. Carroll,et al.  Warfarin Monitoring in Ambulatory Older Individuals Receiving Antimicrobial Therapy , 2005, Pharmacotherapy.

[6]  Mark Crowther,et al.  Systematic overview of warfarin and its drug and food interactions. , 2005, Archives of internal medicine.

[7]  K. Fahrbach,et al.  Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. , 2004, Chest.

[8]  W. Ghali,et al.  Venous thromboembolism according to age: the impact of an aging population. , 2004, Archives of internal medicine.

[9]  M. Gent,et al.  Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism , 2004 .

[10]  David B. Matchar,et al.  Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-Management , 2000, Journal of Thrombosis and Thrombolysis.

[11]  D. Horstkotte,et al.  Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease , 2004, Journal of Thrombosis and Thrombolysis.

[12]  J. Douketis,et al.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.

[13]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[14]  G. Samsa,et al.  Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. , 2002, The American journal of medicine.

[15]  W. Aronow,et al.  Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  J. Gurwitz,et al.  Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. , 2001, Archives of internal medicine.

[17]  L. Melton,et al.  Incidence of venous thromboembolism in hospitalized patients vs community residents. , 2001, Mayo Clinic proceedings.

[18]  D. Witter,et al.  Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. , 2000, Archives of internal medicine.

[19]  Rose Anne Kenny,et al.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[20]  J. Avorn,et al.  Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. , 1997, Archives of internal medicine.

[21]  L K Gottlieb,et al.  Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice? , 1994 .

[22]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.